A randomized, controlled clinical trial comparing remimazolam to propofol when combined with alfentanil for sedation during ERCP procedures

阿芬太尼 医学 异丙酚 麻醉 镇静 随机对照试验 外科
作者
Shuan Dong,Yan Guo,Shasha Liu,Lili Wu,Lina Wu,Kai Song,Jinghua Wang,Huirong Chen,Weizhi Li,Huan-Xi Li,Li Zhang,Jianbo Yu
出处
期刊:Journal of Clinical Anesthesia [Elsevier BV]
卷期号:86: 111077-111077 被引量:53
标识
DOI:10.1016/j.jclinane.2023.111077
摘要

In many countries, the combination of propofol and opioid is used as the preferred sedative regime during ERCP. However, the most serious risks of propofol sedation are oxygen deficiency and hypotension. Compared to midazolam, remimazolam has a faster onset and offset of hypnotic effect, as well as cardiorespiratory stability, and to achieve widespread acceptance for procedural sedation, remimazolam must replace propofol which is the most commonly used for procedural sedation. The objective of this study was to compare the safety and efficacy profiles of the remimazolam and propofol when combined with alfentanil for sedation during ERCP procedures. A randomized, controlled, single-center trial. The Endoscopic Centre of Tianjin Nankai Hospital, China. 518 patients undergoing elective ERCP under deep sedation. Patients scheduled for ERCP were randomly assigned to be sedated with either a combination of remimazolam-alfentanil or propofol-alfentanil. The primary outcome was the prevalence of hypoxia, which was defined as SpO2 < 90% for >10 s. Other outcomes were the need for airway maneuver, procedure, and sedation-related outcomes and side effects (e.g., nausea, vomiting, and cardiovascular adverse events). A total of 518 patients underwent randomization. Of these, 250 were assigned to the remimazolam group and 255 to the propofol group. During ERCP, 9.6% of patients in the remimazolam group showed hypoxia, while in the propofol group, 15.7% showed hypoxia (p = 0.04). The need for airway maneuvering due to hypoxia was significantly greater in the propofol group (p = 0.04). Furthermore, patients sedated with remimazolam had a lower percentage of hypotension than patients sedated with propofol (p < 0.001). Patients receiving remimazolam sedation expressed higher satisfaction scores and were recommended the same sedation for the next ERCP. The procedure time in the remimazolam group was much longer than in the propofol group due to the complexity of the patient's disease, which resulted in a longer sedation time. During elective ERCP, patients administered with remimazolam showed fewer respiratory depression events under deep sedation with hemodynamic advantages over propofol when administered in combination with alfentanil.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
lpx43完成签到,获得积分10
刚刚
zz2905发布了新的文献求助10
3秒前
一蓑烟雨完成签到,获得积分10
3秒前
3秒前
5秒前
崔崔发布了新的文献求助10
6秒前
ff不吃芹菜完成签到,获得积分10
7秒前
叶子完成签到,获得积分10
7秒前
唐唐完成签到,获得积分10
8秒前
123发布了新的文献求助10
8秒前
11秒前
朵朵完成签到,获得积分10
13秒前
发呆的小号完成签到 ,获得积分10
13秒前
充电宝应助原本采纳,获得10
15秒前
山260完成签到 ,获得积分10
15秒前
badada完成签到,获得积分10
15秒前
田様应助科研通管家采纳,获得10
17秒前
大模型应助科研通管家采纳,获得10
17秒前
科研通AI2S应助科研通管家采纳,获得10
17秒前
伶俐乐菱应助科研通管家采纳,获得10
18秒前
18秒前
18秒前
18秒前
shadow完成签到,获得积分10
19秒前
sen123完成签到,获得积分10
20秒前
123完成签到,获得积分20
21秒前
22秒前
NATURECATCHER完成签到,获得积分10
22秒前
温暖霸完成签到,获得积分10
22秒前
以筱完成签到,获得积分10
23秒前
NexusExplorer应助崔崔采纳,获得10
23秒前
CipherSage应助Passskd采纳,获得10
27秒前
28秒前
子睿完成签到,获得积分10
28秒前
背后雨柏完成签到 ,获得积分10
28秒前
29秒前
nanana发布了新的文献求助10
30秒前
量子星尘发布了新的文献求助10
30秒前
五月初夏完成签到,获得积分10
30秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038235
求助须知:如何正确求助?哪些是违规求助? 3575992
关于积分的说明 11374009
捐赠科研通 3305760
什么是DOI,文献DOI怎么找? 1819276
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022